Active
Updated 7/15/2025 12:00:00 AM

Evp Pharmaceuticals, Inc.

Evp Pharmaceuticals, Inc. is a Stock Corporation located in Phoenix, AZ. Established on December 13, 2019, this corporation is officially registered under the document number 4536691 with the California Secretary of State. It currently holds an active status.

The primary and mailing address of the corporation is 711 E. Carefree Hwy, Suite 140, Phoenix, AZ 85085, which serves as the corporation's central base for business operations and communication.

To maintain legal compliance, the corporation has appointed Csc - Lawyers Incorporating Service as its official registered agent, located at 251 Little Falls Drive, Wilmington, DE 19808.

Filing information

Company Name Evp Pharmaceuticals, Inc.
Entity type Stock Corporation
Governing Agency California Secretary of State
Document Number 4536691
Date Filed December 13, 2019
Company Age 5 years 7 months
State AZ
Status Active
Formed In Delaware
Standing
Secretary of State Good
Franchise Tax Board Good
Agent Good
Victims of Corporate Fraud Compensation Fund Good
Type of Business HOLDING COMPANY

The data on Evp Pharmaceuticals, Inc. was extracted from the California Secretary of State's Registry (https://bizfileonline.sos.ca.gov/search/business/) as of 7/15/2025.

Contact details

Principal Address

711 E. Carefree Hwy, Suite 140
Phoenix, AZ 85085

Mailing Address

711 E. Carefree Hwy, Suite 140
Phoenix, AZ 85085

Agent

1505 Corporation
Csc - Lawyers Incorporating Service
251 Little Falls Drive
Wilmington, DE 19808

Principal(s)

Chief Financial Officer
Ajoy Karna
12 Mountfort Street
Portland, ME 04101
Chief Executive Officer
Matthew Yordy
12 Mountfort Street
Portland, ME 04101
Secretary
Tamika Simmons
7 Mountfort St
Portland, ME 04101

Events

Event Type
Filed Date
Effective Date
Description
Event Type Statement of Information
Filed Date 11/26/2024
Effective Date
Description

Annual Report Due Date
From: 12/31/2024 12:00:00 Am
To: 12/31/2025 12:00:00 Am

Event Type Statement of Information
Filed Date 11/22/2023
Effective Date
Description
Event Type Initial Filing
Filed Date 12/13/2019
Effective Date
Description

Document Images